New hope for advanced cancer: ASKB589 trial underway
Disease control
Ongoing
This study tests a new drug called ASKB589 in people with advanced or metastatic solid tumors, especially stomach and pancreatic cancers. The main goals are to check safety, find the right dose, and see if the drug can shrink tumors. About 199 participants will take part in this …
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 09:02 UTC